Has Cleon Hubbard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,624 in general payments to Cleon Hubbard, MD across 48 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cleon Hubbard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cleon Hubbard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cleon Hubbard, MD

Cardiovascular Disease · Wormleysburg, PANPI 1043279946

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $5,100 of the $7,624 with a category attached, or 66.9%. Medtronic accounts for 85.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $5,459 and has fallen 90.8% since, to $502 in 2025.

$7,624in general payments, 2019–2025

Across 48 payments — averaging $158.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$7K
Inari Medical, Inc.$339
Bard Peripheral Vascular, Inc.$274
Abiomed$134
Cardiovascular Systems Inc.$105
Penumbra, Inc.$83
plus $140 from 5 others

$61,545in research payments, 2019–2025

Across 37 payments — averaging $1663.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Trireme Medical LLC$41K
Medtronic$15K
W. L. Gore & Associates, Inc.$5K

What the payments were for

Speaking & faculty fees$5,10067%
Travel & lodging$4336%
Food & beverage$2,09027%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	28	$6,550
Inari Medical, Inc.	2	$339
Bard Peripheral Vascular, Inc.	6	$274
Abiomed	2	$134
Cardiovascular Systems Inc.	1	$105
Penumbra, Inc.	1	$83
Boston Scientific	3	$50
Shockwave Medical, Inc	2	$39
Amarin Pharma, Inc.	1	$18
E.r. Squibb & Sons, L.L.C.	1	$17
Terumo Medical Corporation	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,624 in reported general payments places this provider in the 80th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$144,309

Medicare patients

1,021

Services billed

1,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	213	$246,771
XareltoRivaroxaban	54	$63,386
Repatha SureclickEvolocumab	61	$49,962
JardianceEmpagliflozin	37	$36,585
EntrestoSacubitril/Valsartan	28	$28,114
Praluent PenAlirocumab	11	$12,794
Metoprolol Succinate	589	$12,315
BrilintaTicagrelor	11	$7,209
Rosuvastatin Calcium	309	$7,067
ClopidogrelClopidogrel Bisulfate	373	$5,289
Atorvastatin Calcium	357	$4,717
Diltiazem 24hr Er (Cd)Diltiazem Hcl	93	$2,767
Ranolazine ErRanolazine	35	$2,736
Losartan Potassium	150	$2,371
Amiodarone Hcl	66	$2,366

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Wormleysburg

Hemal GadaWormleysburg$1.8M
Benjamin KalsmithPgh$1.7M
Peter KoweyWynnewood$1.5M
Paul ForfiaPhiladelphia$1.2M
Quang BuiPhiladelphia$933K
Rhian DaviesYork$853K
Sarang MangalmurtiBryn Mawr$728K
Sabahat BokhariAllentown$578K
George GabrielPittsburgh$563K
Rajesh DaveCamp Hill$442K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →